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Research
Historically, silver (Ag) compounds have been 
used in numerous fields to prevent microbial 
growth. Like many non  essential heavy met­
als, Ag is a natural biocide, but compared 
with titanium, zinc, and copper, Ag nano­
particles (Ag­nps) show the highest anti­
microbial efficacy against bacteria, viruses, 
and other eukaryotic micro  organisms (Gong 
et al. 2007). The Phoenicians coated milk 
bottles with Ag to inhibit bacterial growth; 
doctors have adminis  tered drops of Ag nitrate 
solutions to newborn babies to prevent neo­
natal conjunctivitis (Crede 1881); and Ag 
sulfa  diazine creams have long been consid­
ered the standard of care for the preven­
tion of widespread bacterial growth on burn 
patients’ denuded skin (Moyer et al. 1965). 
Both dietary supplements and homemade 
varieties of Ag colloids have been sold for 
decades as a “cure­all” for such diseases as 
tuberculosis, syphilis, scarlet fever, shingles, 
herpes, pneumonia, and arthritis (National 
Center for Complementary and Alternative 
Medicine 2009). Furthermore, advances in 
nano  technology have facilitated the increase 
of Ag­containing merchandise available to 
the public, making Ag the most used nano­
material of all manufacturer­identified 
products in the world (Project on Emerging 
Nanotechnologies 2009). Products such as 
room deodorizing sprays, acne creams, cloth­
ing that prevents body odor, baby wipes, 
and pacifiers all exploit the natural anti­
microbial activity of Ag (Project on Emerging 
Nanotechnologies 2009). In a study inves­
tigating the release of Ag­nps from com­
mercially available sock fabric, Benn and 
Westerhoff (2008) showed that socks could 
contain up to 1,360 µg Ag/g per sock and 
could release as much as 1.3 µg/mL of Ag 
into distilled water. 
Ingestion of Ag can cause argyria, the 
benign condition characterized by the bluish­
graying of the skin that occurs through the 
preferential deposition of Ag in the basal lam­
ina of soft tissues such as the skin, liver, and 
spleen (Fung and Bowen 1996) and blood 
vessels, gastro  intestinal tract, liver, and kidney 
(Danscher 1980). Although argyria is most 
commonly reported clinically after exces­
sive Ag ingestion, Ag deposition has been 
seen after treatment of burned skin with Ag 
sulfa  diazine (Lee and Lee 1994; Marshall and 
Schneider 1977; Temple and Farooqi 1985). 
In response to argyria, but not to Ag toxic­
ity, the National Institute for Occupational 
Safety and Health (2003) set a daily exposure 
limit for all forms of Ag at 0.01 mg/m3, and 
the U.S. Environmental Protection Agency 
(2003) established the oral reference dose at 
0.005 mg/kg/day. 
Studies indicating Ag toxicity exist from 
as early as 1983, when Rungby and Danscher 
(1983) showed that Ag salts intra  peritoneally 
adminis  tered to rats can accumulate in neurons 
and in protoplasmic glial cells of the brain and 
spinal cord. In vitro cell line studies have shown 
decreased mitochondrial function after expo­
sure to Ag­nps in murine neuro  blastoma cells 
(Schrand et al. 2008), hepatic cells (Hussain 
et al. 2005), germ  line stem cells (Braydich­
Stolle et al. 2005), human skin carcinoma cells 
(Arora et al. 2008), and human epidermal kera­
tinocytes (HEKs) and fibroblasts (Burd et al. 
2007). Although in vivo studies have not been 
performed with Ag­nps, poly  vinyl  pyrrolidone­
stabilized Ag­nps with a mean size of 25 nm 
were shown to penetrate into the upper lay­
ers of the epidermis in excised human skin in 
static diffusion cells (Larese et al. 2009). Other 
nano  materials, such as quantum dots (QDs) 
and fullerenes (Rouse et al. 2006; Ryman­
Rasmussen et al. 2006; Zhang and Monteiro­
Riviere 2008; Zhang et al. 2008), as well as zinc 
oxide (Cross et al. 2007; Gamer et al. 2006), 
are able to penetrate into the stratum corneum; 
thus, examination of the ability of Ag­nps to 
penetrate the skin is warranted.
Our objectives in this study were to 
determine the optimal viability assay for use 
with Ag­nps in order to assess their toxicity 
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In t r o d u c t I o n: Products using the antimicrobial properties of silver nanoparticles (Ag-nps) may be 
found in health and consumer products that routinely contact skin.
objectIves: This study was designed to assess the potential cytotoxicity of Ag-nps in human epi-
dermal keratinocytes (HEKs) and their inflammatory and penetrating potential into porcine skin 
in vivo.
Ma t e r I a l s a n d Me t h o d s: We used eight different Ag-nps in this study [unwashed/uncoated (20, 
50, and 80 nm particle diameter), washed/uncoated (20, 50, and 80 nm), and carbon-coated (25 and 
35 nm)]. Skin was dosed topically for 14 consecutive days. HEK viability was assessed by MTT,   
alamarBlue (aB), and CellTiter 96 AQueous One (96AQ). Release of the pro  inflammatory mediators 
interleukin (IL)-1β, IL-6, IL-8, IL-10, and tumor necrosis factor-α (TNF-α) were meas  ured.
re s u l t s: The effect of the unwashed Ag-nps on HEK viability after a 24-hr exposure indicated a 
significant dose-dependent decrease (p < 0.05) at 0.34 µg/mL with aB and 96AQ and at 1.7 µg/mL   
with MTT. However, both the washed Ag-nps and carbon-coated Ag-nps showed no signifi-
cant decrease in viability at any concentration assessed by any of the three assays. For each of the 
unwashed Ag-nps, we noted a significant increase (p < 0.05) in IL-1β, IL-6, IL-8, and TNF-α con-
centrations. We observed localization of all Ag-nps in cyto  plasmic vacuoles of HEKs. Macroscopic 
observations showed no gross irritation in porcine skin, whereas microscopic and ultrastructural 
observations showed areas of focal inflammation and localization of Ag-nps on the surface and in 
the upper stratum corneum layers of the skin.
co n c l u s I o n: This study provides a better understanding Ag-nps safety in vitro as well as in vivo 
and a basis for occupational and risk assessment. Ag-nps are non  toxic when dosed in washed Ag-nps 
solutions or carbon coated.
Key w o r d s : keratinocytes, metal oxides, nanoparticles, nanotechnology, porcine skin, silver, skin 
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to skin cells, their inflammatory potential, 
and capacity to penetrate skin.
Materials and Methods
Ag-nps. To encompass the variety of manufac­
tured Ag­nps on the market, we used eight dif­
ferent forms of Ag­nps with different sizes and 
surface conditions (Table 1). All Ag­nps used 
in this study were supplied by nanoComposix   
(San Diego, CA): commercially used unwashed 
and uncoated Ag­nps suspended in deionized 
water with diameters of 20, 50, and 80 nm 
(“unwashed”); washed and uncoated Ag­nps 
suspended in deionized water with diameters of 
20, 50, and 80 nm (“washed”); and commer­
cially used dried carbon­coated Ag­nps with 
diameters of 25 and 35 nm (“carbon­coated”). 
The sizes of each type of Ag­nps were deter­
mined by the manufacturer and confirmed in 
this study by dynamic light scattering (DLS) 
and transmission electron microscopy (TEM).
Both the unwashed and washed Ag­nps 
were synthesized by ammonium hydroxide– 
catalyzed growth of Ag onto 5­nm gold seed 
particles. Concentration of the particles was 
achieved via tangential flow filtration. The 
unwashed Ag­nps solution contained approxi­
mately 5.55 mg/mL formaldehyde solvent 
and methanol by­product from their forma­
tion. These unwashed Ag­nps were then ultra­
centrifuged to obtain the solution super  natant 
for toxicity testing (“as synthesized” super­
natant). The Ag­nps were then serially washed 
with 20 vol equivalents of 2 mM phosphate 
buffer (pH 7.5) and the 5, 10, 15, and 20 
washing permeates were collected. The wash­
ing permeates contained 20–50 ppb dissolved 
Ag. The colloidal Ag­nps were stored at 4°C in 
the dark. The carbon­coated Ag­nps, synthe­
sized by pulsed plasma reactor and coated with 
poly  aromatic graphitic carbon, were supplied 
as a powder and stored at room temperature.
Cell culture. Cryopreserved primary neo­
natal HEKs (Lonza, Walkersville, MD) were 
grown in Keratinocyte Growth Medium­2 
(KGM­2; Lonza) in cell culture flasks (75 cm2; 
1,000,000 cells) to approximately 80% 
confluency in a 37°C humidified 5% CO2 
incubator. The cells were passed into clear or 
black 96­well microplates (12,500 cells/well; 
200 µL) in which the peripheral wells con­
tained only KGM­2 to prevent the evapora­
tion of treatment medium. Between 18 and 
24 hr later, after reaching approximately 80% 
confluency, the HEKs were exposed to either 
KGM­2 (control) or serial dilutions of each 
Ag­nps type for the following experiments.
Evaluation of best viability assay. A nano­
particle (no­cell) control (nanoparticles in 
collagen­coated wells with no HEKs) and a 
nanoparticle/cell control (nanoparticles exposed 
to HEK­metabolized assay dye) were run in 
parallel with each viability assay as described 
by Monteiro­Riviere et al. (2009) to assess the 
interactions between the viability assays and 
the Ag­nps [see Supplemental Material avail­
able online (doi:10.1289/ehp.0901398.S1 via 
http://dx.doi.org/)].
Ag-nps treatment of HEKs. We conducted 
an initial dose–response study to assess the 
concentrations of Ag­nps that could affect 
HEK after 24­hr exposure. Most of the col­
loidal Ag­nps tested were supplied in both 
low volume and concentration, which limited   
the highest HEK dosing concentration to 
1.7 µg/mL. Combined with KGM­2 medium, 
a 1.7 µg/mL solution of the Ag­nps was serially 
diluted (1:5) to provide concentrations rang­
ing from 1.7 to 0.000544 µg/mL. The effect of 
the Ag­nps on HEK viability was assessed by 
three different toxicity assays: 3­(4,5­dimethyl­
thiazol­2­yl)­2,5­diphenyltetrazolium bro­
mide (MTT; Sigma­Aldrich, St. Louis, MO),   
alamarBlue (aB; Molecular Probes, Invitrogen, 
Eugene, OR), and CellTiter 96 AQueous One 
(96AQ; Promega, Madison, WI) [for details, 
see Supplemental Material (doi:10.1289/
ehp.0901398.S1 via http://dx.doi.org/)].
We tested dosing concentrations of the 
washed and carbon­coated Ag­nps up to 
42.5 µg/mL but saw no response. Additionally, 
to differentiate the potential cyto  toxicity 
between the particles and the contaminants 
present in the colloidal solution, HEKs were 
treated with the “as synthesized” supernatant 
and the 5, 10, 15, and 20 washing perme­
ate for 24 hr at concentrations ranging from 
1.7 µg/mL to 0.068 µg/mL.
Cytokine release. For the concentrations 
of Ag­nps that showed toxicity, we conducted 
cytokine analysis to determine their pro­
inflammatory potential by assessing the release 
of interleukin (IL)­8, IL­6, tumor necrosis 
factor­α (TNF­α), IL­10, and IL­1β; the 
procedure is described in the Supplemental 
Material (doi:10.1289/ehp.0901398.S1).
In vivo porcine skin exposure. We com­
pared the effects of unwashed Ag­nps with 
those of washed Ag­nps in vivo. Assuming 
the two smallest Ag­nps could penetrate the 
skin, the comparison was limited to the 20­ 
and 50­nm washed and unwashed samples. 
Pigs were dosed on the back skin with Ag­nps 
solutions ranging from 34.0 to 0.34 µg/mL   
[for details, see Supplemental Material 
(doi:10.1289/ehp.0901398.S1)]. Skin was 
evaluated for erythema and edema according 
to the Draize system (Draize et al. 1944): for 
erythema: 0, no change; 1, very slight change; 
2, pale red in defined area; 3, definite red in 
well­defined area; 4, crimson red; and for 
edema: 0, no change; 1, very slight change; 
2, slight change with edges barely defined; 
3, moderate change, with area raised 1 mm; 
4, severe change, with area raised > 1 mm 
and extending beyond the exposure area. All 
Table 1. Ag-nps properties.
Description
MDD 
(nm)
DLS  
diameter 
(nm)a
TEM 
diameter 
(nm)a
Supplied 
concentration 
(mg/mL)
Particle 
concentration 
(particles/mL)a
Zetab 
potential 
(mV)
Unwashed, colloid 20 30.8 ± 0.6 22.4 ± 2.6 0.20 2.41 × 1012 –29.7
50 47.7 ± 0.5 49.4 ± 6.2 0.20 4.44 × 1011 –27.8
80 75.5 ± 1.0 79.2 ± 8.0 0.20 7.09 × 1010 –33.2
Washed, colloid 20 25.5 ± 0.4 21.4 ± 3.1 2.86 1.89 × 1014 –46.0
50 43.7 ± 1.1 50.0 ± 5.9 3.45 5.01 × 1012 –44.3
80 79.9 ± 28.0 77.0 ± 6.0 2.79 1.07 × 1012 –43.7
Carbon-coated, powder 25 149.0 ± 89 27.2 ± 10.3 NA NA –24.0
35 167.0 ± 110 37.0 ± 11.6 NA NA –29.0
Abbreviations: MDD, manufacturer-designated diameter; NA, not applicable.
aMean ± SD. bZeta potential in deionized water.
Table 2. Significant change in absorbance or fluorescence values (μg/ml Ag-nps/mL media) in control 
studies by assay.
No cell controla  Cell controlb
Ag-nps MTT aB 96AQ MTT aB 96AQ
Unwashed
20 nm 1.7 — 1.7 — — —
50 nm 0.34 — 1.7 — — —
80 nm 1.7 — 1.7 — — —
Washed 
20 nm — 0.34 1.7c — — —
50 nm — 1.7 1.7 — — —
80 nm 1.7 1.7 1.7 — — —
Carbon-coated
25 nm 1.7 — 1.7 1.7 — —
35 nm 1.7 — 0.34 1.7 — —
—, No change in absorbance or fluorescence value was found, indicating a lack of interaction between assay and Ag-nps.
aNo cell control value at which a significant increase in absorbance or fluorescence was observed (p < 0.05). bCell con-
trol value at which a significant increase in absorbance was observed before and after Ag-nps (p < 0.05). cA significant 
decrease was observed for this data set. Silver nanoparticle toxicity in vitro and in vivo
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animals were treated humanely and with regard 
for alleviation of suffering.
Microscopic observations. To assess mor­
phologic alterations during the in vivo study, 
we harvested tissue samples after the pigs 
were euthanized and processed them rou­
tinely for light microscopy [see Supplemental 
Material (doi:10.1289/ehp.0901398.S1)]. 
Approximately 1­cm sections were evaluated 
for inter  cellular and intra  cellular epidermal 
edema, dermal edema, and inflammation 
using the following scoring system: 0, no 
change; slight, inflammation on less than half 
the sample; moderate, inflammation on half 
the sample; severe, inflammation on more 
than half the sample.
Ultrastructural observations. Particle 
size analysis was conducted with both DLS 
and TEM to confirm the manufacturer­
identified diameters and surface characteriza­
tion [for details, see Supplemental Material 
(doi:10.1289/ehp.0901398.S1)]. To localize 
Ag­nps uptake in vitro, HEKs were grown to 
approximately 70% confluency in cell cul­
ture flasks (25 cm2) and treated for 24 hr with 
each Ag particle at 1.7 µg/mL in KGM­2. The 
cells and skin samples were processed rou­
tinely for TEM (for details, see Supplemental 
Material). We viewed all TEM samples on an 
FEI/Philips EM 208S TEM (FEI, Hillsboro, 
OR), operating at an accelerating voltage of 
80 kV. Additionally, unstained samples were 
analyzed by X­ray micro  analysis [energy 
dispersive X­ray spectroscopy (EDS)] with 
a Hitachi HF2000 FE TEM (Hitachi High 
Technologies America Inc., Lexington, KY) 
equipped with an Oxford Instruments INCA 
EDS (Oxford Instruments, Oxfordshire, UK).
Statistical analysis. We calculated the 
mean values for HEK percent viability (nor­
malized by viability) and cytokine concen­
tration for each treatment and determined 
the significant differences (p < 0.05) using the 
PROC GLM procedure (SAS, version 9.1 
for Windows; SAS Institute Inc., Cary, NC). 
When significant differences were found, we 
performed multiple comparisons using the 
Tukey’s studentized range highest significant 
difference test, with p < 0.05 as the level of 
significance. Dunnett’s t­test was performed to 
determine the significance at p < 0.5 of differ­
ences between control and treatment groups. 
Data are expressed as the mean ± SEM of two 
plates (n = 6/plate).
Results
Evaluation of viability assays. Table 2 summa­
rizes the control studies for the three viability 
assays, listing the absorbance or fluorescence 
value for each Ag­nps type that shows a signifi­
cant inter  action. For MTT, at 1.7 µg/mL both 
the 25­nm (Figure 1A) and 35­nm (Figure 1B) 
carbon­coated Ag­nps nano  particle/cell con­
trols show a statistically significant increase 
in absorbance after exposure of Ag­nps to 
cell­reacted assay dye. The nano  particle (no 
cell) controls showed a statistically significant 
increase in absorbance at 1.7 µg/mL with the 
20­nm unwashed Ag­nps for 96AQ and MTT 
but not for aB (Figure 1C).
All other nanoparticle control data are 
available in the Supplemental Material 
(doi:10.1289/ehp.0901398.S1). We saw 
no significant changes in the fluorescence 
values for aB for the 20­, 50­, or 80­nm 
unwashed Ag­nps (see Supplemental Material, 
Figure 1a). The unwashed 50­ and 80­nm 
Ag­nps caused a significant increase in absor­
bance values for MTT and 96AQ but not for 
aB (see Supplemental Material, Figure 1b,c). 
The fluorescence value for aB increased sig­
nificantly at 0.034 µg/mL for both 20­ and 
50­nm washed Ag­nps and at 1.7 for 80­nm 
washed Ag­nps (see Supplemental Material, 
Figure 2a). The absorbance value for 96AQ 
changed significantly at 1.7 µg/mL for each 
of the 20­, 50­, and 80­nm washed Ag­nps 
(see Supplemental Material, Figure 2b). 
The 80­nm washed Ag­nps caused a signifi­
cant increase in absorbance value for MTT 
at 1.7 µg/mL (see Supplemental Material, 
Figure 2c). The fluorescence value for aB 
increased significantly at 1.7 µg/mL for 35­nm 
carbon­coated Ag­nps (see Supplemental 
Material, Figure 3a). The absorbance value 
increased significantly for 96AQ at 1.7 µg/mL   
for 25­nm carbon­coated Ag­nps and at 
0.034 µg/mL for 35­nm carbon­coated Ag­nps 
(see Supplemental Material, Figure 3b). 
We observed a significant increase in the 
absorbance value for MTT at 1.7 µg/mL   
for 25­ and 35­nm carbon­coated Ag­nps (see 
Supplemental Material, Figure 3c). 
Ag-nps treatment of HEK. Generally, for 
concentrations ranging from 0.000544 to 
1.7 µg/mL and exposures of 24 hr, treatment 
with unwashed Ag­nps resulted in a dose­
dependent decrease in viability with all three 
Figure 1. Evaluation of Ag-nps and HEK viability after 24 hr exposure to Ag-nps. Nanoparticle/cell control of HEKs before and after treatment with 25-nm (A) or 
35-nm carbon-coated Ag-nps (B) assessed by MTT. (C) Nanoparticle controls (no cells) of 20 nm unwashed Ag-nps assessed by 96 AQ, MTT, and aB. (D) HEK 
viability after 24 hr exposure to various Ag-nps as assessed by aB.
*p < 0.05; nanoparticle/cell controls were compared for each concentration before and after Ag-nps, nanoparticle controls were run with multiple comparisons between concentrations, 
and each Ag-nps type was assessed independently. In D, different letters denote significant differences for each nanoparticle at each concentration (p < 0.05); each Ag-nps type was 
assessed independently.
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assays, whereas for the washed and carbon­
coated Ag­nps there was no decrease in viabil­
ity for any assay. 
As shown in Figure 1D, the 20­ and 
50­nm unwashed Ag­nps caused a significant 
decrease in viability at 0.34 µg/mL for both 
aB and 96AQ and at 1.7 µg/mL for MTT. 
The 80­nm unwashed Ag­nps caused a sig­
nificant decrease in viability at 0.34 µg/mL 
for all three assays. The “as synthesized” 
supernatant showed a significant decrease in 
viability at 0.34 µg/mL for the MTT and aB 
assays and at 1.7 µg/mL for 96AQ. Toxicity 
was not present for any of the supernatants 
obtained from the 5, 10, 15, or 20 wash­
ing permeates. HEKs exposed for 24 hr to 
washed 20­, 50­, or 80­nm Ag­nps or the 
carbon­coated Ag­nps ranging in concentra­
tion from 0.000544 to 1.7 µg/mL showed 
no significant decrease in viability with any 
assay [see Supplemental Material, Figures 4–6 
(doi:10.1289/ehp.0901398.S1)].
Cytokine release. We observed a signifi­
cant increase above the limit of detection in 
IL­1β (Figure 2A), IL­6 (Figure 2B), IL­8 
(Figure 2C), and TNF­α (Figure 2D) from 
HEKs exposed to 0.34 µg/mL unwashed 20­, 
50­, and 80­nm Ag­nps for 24 hr. The lowest 
limit of detection for IL­1β was 0.8 pg/mL;   
IL­6, 1.1 pg/mL; IL­8, 0.5 pg/mL; and 
TNF­α, 3.0 pg/mL. The values for IL­10 
were less than the detectable limit of the assay 
(0.9 pg/mL).
Macroscopic observations of topically 
applied Ag-nps on porcine skin. We noted no 
gross erythema or edema based on the Draize 
system in any of the treated sites during the 
entire 14­day in vivo study. Treated sites were 
gray in appearance, representing residual 
Ag­nps on the surface of the skin.
Microscopic observations. Morphologic 
observations of untreated porcine skin exhib­
ited normal epidermis and dermis (Figure 3A). 
Skin dosed daily with Ag­nps for 14 days 
exhibited a concentration­dependent response, 
regardless of particle size or if washed or 
unwashed. Skin treated with the lowest dosing 
concentration of 0.34 µg/mL 20­nm washed 
Ag­nps typically showed a slight intra  cellular 
and inter  cellular epidermal edema (Figure 3B); 
with 3.4 µg/mL of 20­nm washed Ag­nps 
there was moderate focal intra  cellular and 
inter  cellular epidermal edema and focal epi­
dermal and dermal inflammation (Figure 3C). 
Skin treated with the highest concentration of 
20­nm washed Ag­nps (34 µg/mL) showed 
severe intra  cellular and inter  cellular epidermal 
edema with severe focal dermal inflammation 
(spongiosis), epidermal hyperplasia, and para­
keratosis. Also, the extension of the rete pegs 
increased into the superficial papillary layer of 
the dermis (Figure 3D).
Results for the 20­nm unwashed Ag­nps 
[see Supplemental Material, Figure 7 
(doi:10.1289/ehp.0901398.S1)] were similar 
to those for the 20­nm washed Ag­nps. In skin 
treated with 0.34 µg/mL of 20­nm unwashed 
Ag­nps, we observed slight intra  cellular epider­
mal edema; with 3.4 µg/mL, moderate intra­
cellular and inter  cellular epidermal edema; 
and with 34 µg/mL, severe intracellular and 
inter  cellular epidermal edema with focal areas 
of intra  epidermal infiltrates and superficial 
papillary dermal inflammation.
Figure 2. Cytokine release by HEKs treated with 20-, 50-, or 80-nm unwashed Ag-nps. (A) IL-1β. (B) IL-6. 
(C) IL-8. (D) TNF-α. 
*p < 0.05, by multiple comparisons between concentrations, with each Ag-nps type assessed independently.
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Figure 3. Light micrographs showing effects of 20-nm washed Ag-nps on porcine skin (stained with hema-
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arrowheads, peri  vascular inflammation. Bars = 60 µm.Silver nanoparticle toxicity in vitro and in vivo
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Ultrastructural observations of HEKs 
exposed to Ag-nps. Ultrastructural observations 
of the 20­nm washed and 25­nm carbon­ 
coated Ag­nps are shown in Figure 4A and B 
[for all other Ag­nps, see Supplemental 
Material, Figure 8 (doi:10.1289/ehp.0901398.
S1)]. The HEK controls appeared normal, 
with prominent nucleus, nucleolus, and mito­
chondria (Figure 4C). In HEKs dosed with 
Ag­nps of all sizes and surface conditions, 
Ag­nps were localized within membrane­ 
bound cytoplasmic vacuoles; Figure 4D 
shows a representative image of internalized 
Ag­nps (for all other Ag­nps electron micro­
graphs, see Supplemental Material, Figure 9). 
EDS analysis of HEKs dosed with the 20­nm 
washed Ag­nps confirmed the presence of Ag 
in the vacuoles; copper from the grid and 
gold from the particle seed were present (see 
Supplemental Material, Figure 10).
The control skin consisted of a normal 
compact stratum corneum with approxi­
mately 20–30 layers attached by desmo­
somes (Figure 4E). For skin dosed daily for 
14 days, all Ag­nps localization was within 
or on top of the stratum corneum. TEM 
images show the presence of Ag­nps within 
the superficial layers of the stratum corneum 
of skin dosed with 34 µg/mL 50­nm washed 
Ag­nps (Figure 4F), and on top of the stratum 
corneum of skin dosed with 20­nm washed 
Ag­nps [see Supplemental Material, Figure 9H 
(doi:10.1289/ehp.0901398.S1)]. EDS analy  sis 
conducted in these areas detected Ag, osmium 
from the post  fixation process, and copper 
from the grid (see Supplemental Material, 
Figure 10).
Discussion
Ag­nps have been integrated into hundreds 
of products that affect the daily lives of mil­
lions of people in many countries. Their main 
use is for disinfection in wound care and in 
products such as odor­reducing clothing, acne 
creams, and face masks. Most of these prod­
ucts come into direct contact with skin, the 
largest organ of the human body, and could 
serve as a potential route for nano  particle 
penetra  tion. Therefore, the relationship of 
Ag­nps in skin needs to be investigated with 
particular focus on their irritation potential, 
toxicity, and penetration into skin and skin 
cells. In this study we evaluated the cyto  toxic 
potential of Ag­nps of varying sizes and sur­
face conditions in HEK cells, their penetrat­
ing capacity into porcine skin after topical 
repetitive daily dosing for 2 weeks, and the 
localization of the Ag­nps within HEKs and 
porcine skin.
The use of several viability assays is impor­
tant to determine the optimal assay to assess 
Ag­nps toxicity; therefore, mortality of HEKs 
after Ag­nps exposure was evaluated with 
three different assays that use colorimetric or 
fluorescent dyes as markers to determine cell 
viability by assessing cell metabolism.
Nanomaterials, such as single­walled carbon 
nanotubes (Zhang et al. 2007), carbon black 
(Monteiro­Riviere and Inman 2006), fuller­
enes, and QDs (Monteiro­Riviere et al. 2009), 
are capable of interfering with dye and dye 
products in viability assays through the adsorp­
tion of cell medium constituents and cyto­
kines. We assessed the potential interactions 
between assays and Ag­nps using nanoparticle 
and nanoparticle/cell controls, which showed 
an increase in absorbance and fluorescence val­
ues at the highest concentration. The increase 
in absorbance and fluorescence values could 
cause the toxicity of the Ag­nps in HEKs to be 
underestimated. Additionally, the nano  particle/
cell control showed that both the 25­ and 
35­nm carbon­coated Ag­nps interfered with 
the MTT assay at the 1.7 µg/mL concentration 
Figure 4. TEM images of (A) 20-nm unwashed Ag-nps, (B) 25-nm carbon-coated Ag-nps, (C) control HEKs, 
(D) 80-nm washed Ag-nps, (E) control porcine skin, and (F) 34 µg/mL 50-nm washed Ag-nps in stratum 
corneum of porcine skin. Abbreviations: N, nucleus; unstained sections; SC, stratum corneum. Arrows 
indicate Ag-nps. Bars = 100 nm for A and B; 1 µm for C and D; and 500 nm for E and F.Samberg et al.
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because of the increase in absorbance values 
after incubation of the reduced formazan prod­
uct with Ag­nps (Figure 1A,B). Overall, all 
assays were affected by Ag­nps; based on its 
fluorescence values, aB may be the best viabil­
ity assay to use when conducting experiments 
with Ag­nps.
MTT, aB, and 96AQ viability assays 
did not show toxicity for the 25­ and 35­nm 
carbon­coated Ag­nps or for the 20­, 50­, or 
80­nm washed Ag­nps. All three assays also 
showed that the 20­, 50­, and 80­nm unwashed 
Ag­nps contributed to a decrease in HEK 
viability 24 hr after exposure to the 0.34–1.7 
µg/mL concentrations, but there was no size­
dependent decrease in viability. However, the 
difference in toxicity between the unwashed 
and washed Ag­nps is inferred to be due to the 
presence of contaminants in the unwashed solu­
tion such as formaldehyde, which has shown 
to have cyto  toxic effects on cell culture (Ku 
and Billings 1984). In the present study, these 
residual contaminants were removed by the 
fifth washing step, as indicated by the lack of 
cell death after exposure to the 5, 10, 15, and 
20 washing super  natants. We also found that 
Ag­nps of different sizes, surface conditions, 
and synthesis methods are all internalized into 
membrane­bound vacuoles in HEKs, without a 
decrease in viability, after 24 hr.
In vitro cell line studies have shown that 
25 µg/mL of 25­nm Ag­nps in murine neuro­
blastoma cells decreases mitochondrial func­
tion and causes the production of reactive 
oxygen species that could potentially contrib­
ute to neuro  degenerative diseases (Schrand 
et al. 2008). A significant decrease in mito­
chondrial function has been shown in hepatic 
cells after single exposures to 15­ and 100­nm 
Ag­nps at concentrations ranging from 5 to 
50 µg/mL (Hussain et al. 2005), in germline 
stem cells exposed to 10 µg/mL of 15­nm 
Ag­nps (Braydich­Stolle et al. 2005), and 
in HEKs and fibroblasts after exposure to 
approxi  mately 15 µg/mL Ag­nps extracted 
from commercially available Ag­based wound 
dressings with Ag content ranging from 13 to 
934 µg/cm2 (Burd et al. 2007). Interactions 
between Ag­nps ranging in size from 7 to 
20 nm and human skin carcinoma cells 
showed a decrease in mitochondrial function 
and the onset of apoptosis at concentrations 
of 0.78 µg/mL and 1.56 µg/mL, respectively 
(Arora et al. 2008). The toxic concentrations 
of the 20­, 50­, and 80­nm unwashed Ag­nps 
(0.34–1.7 µg/mL) are slightly more sensitive 
in HEKs compared with in vitro toxicity stud­
ies conducted by others in different cell lines, 
although it is important to consider such fac­
tors as agglomeration, surface conditions, size, 
cell lines, and interactions with the assay dye 
products when comparing across studies.
Keratinocytes produce proinflamma­
tory cytokines, such as IL­8, IL­6, TNF­α, 
and IL­1β, that serve as mediators for inflam­
matory and immunologic reactions in skin 
exposed to irritants (Allen et al. 2000, 2001a, 
2001b; Barker et al. 1991; Corsini and Galli 
2000; Grone 2002; Monteiro­Riviere et al. 
2003; Nickoloff et al. 1991). Although differ­
ent toxicants may elicit different responses in 
HEKs, studies in our laboratory have shown 
cytokine release by HEKs in response to jet 
fuel exposure (Allen et al. 2000, 2001a, 2001b; 
Chou et al. 2002, 2003; Monteiro­Riviere 
et al. 2003, 2004), multi  walled carbon nano­
tubes (Monteiro­Riviere et al. 2005), 6­amino­
hexanoic acid­functionalized single­walled 
carbon nanotubes (Zhang et al. 2007), fuller­
enes (Rouse et al. 2007), and QDs (Ryman­
Rasmussen et al. 2006; Zhang et al. 2008). The 
inflammatory potential of Ag­nps was con­
firmed by the increases in IL­1β, IL­6, IL­8, 
and TNF­α detected in the media from HEK 
cell cultures exposed to 0.34 µg/mL of each of 
the unwashed Ag­nps. 
Nanomaterials are also capable of being 
internalized into cells and penetrating through 
skin; QD­621 have the ability to penetrate 
into the inter  cellular lipid layers of the stra­
tum corneum of porcine skin (Zhang et al. 
2008); QD­565 and QD­655, with diverse 
physiochemical properties, have been shown 
to penetrate into the dermis of abraded skin 
(Zhang and Monteiro­Riviere 2008); and 
derivatized fullerenes are localized within the 
inter  cellular space of the stratum granulosum 
layer of flexed excised porcine skin (Rouse 
et al. 2006). Topical application of 26–30 nm 
zinc oxide in a sunscreen formulation on 
in vitro human skin localized nano  particles 
in the upper stratum corneum with minimal 
penetration (Cross et al. 2007), and microfine 
zinc oxide, with a mean size of 80 nm, and 
agglomerates of titanium dioxide < 160 nm 
did not penetrate the porcine stratum cor­
neum layer of in vitro static diffusion cells 
(Gamer et al. 2006).
Porcine skin is an excellent model for 
studying penetration of human skin because 
its thickness and absorption rates are compa­
rable to those of human skin (Bronaugh et al. 
1982; Monteiro­Riviere and Riviere 1996; 
Reifenrath et al. 1984). In the present study, 
we were surprised that after 14 consecutive 
days of topical dosing, the Ag­nps did not 
cause any macro  scopic irritation, although the 
gray appearance of the skin due to the deposi­
tion of Ag­nps may have masked any subtle 
signs of erythema. When viewed microscopi­
cally, focal inflammation and edema increased 
with an increase in Ag­nps concentration. 
The highest concentration consistently caused 
epidermal hyperplasia with elongated exten­
sion of rete pegs down into the dermis, which 
is typical of a chronic irritation reaction as 
reported with exposure to jet fuels (Monteiro­
Riviere et al. 2001; Muhammad et al. 2005). 
TEM depicted the localization of Ag­nps only 
in the super  ficial layers of the stratum cor­
neum, which was similar to results found in a 
static cell diffusion study (Larese et al. 2009), 
and suggests that ionic flux into the epidermis 
could attribute to focal inflammation. Many 
Ag­nps that were not bound to the skin were 
washed away during both the light and elec­
tron microscopy processing techniques, yet 
their location is confirmed with other nano­
particles that were not shown to penetrate into 
the deeper epidermis (Cross et al. 2007; Zhang 
and Monteiro­Riviere 2008).
Conclusion
This study indicates that toxicity of Ag­nps 
in HEKs is influenced by the residual con­
taminants in the Ag­nps solutions, and that 
the Ag­nps themselves may not be responsible 
for an increase in cell mortality. Complete 
characterization of not only the nano  particles 
but also the vehicle is important in order to 
distinguish between Ag­nps and contaminant 
toxicity. Additionally, this study shows that 
20­, 50­, and 80­nm washed and unwashed 
Ag­nps, as well as 25­ and 35­nm carbon­
coated Ag­nps, interfered and/or reacted 
with MTT, 96AQ, and aB viability assays 
and that aB may be the best viability assay 
because of its lower interference with these 
Ag­nps. Because Ag­nps of several types have 
been shown to enter cells and remain on the 
skin, the possibility of Ag­nps entry into the 
body through damaged or abraded skin is 
important to consider, particularly because 
many Ag­containing products are specialized 
for wound care. With the ability for Ag­nps 
to enter HEKs, their degradation within the 
cell may create reactive oxygen species that 
would be damaging to cell machinery and 
DNA (Arora et al. 2008). We observed focal 
inflammation, specifically intra  cellular and 
inter  cellular epidermal edema, after 14 days of 
topical application of Ag­nps to skin. Studies 
that use longer exposures (several weeks) and 
Ag­nps in different vehicles should be car­
ried out, possibly also investigating effects on 
compromised skin. Overall, the present study 
provides knowledge onAg­nps toxicity and 
penetration in vitro and in vivo over 14 days 
and provides a basis for occupational and risk 
assessment.
RefeRences
Allen DG, Riviere JE, Monteiro-Riviere NA. 2000. Identification 
of early biomarkers of inflammation produced by keratino-
cytes exposed to jet fuels jet A, JP-8, and JP-8(100). 
J Biochem Mol Toxicol 14:231–237.
Allen DG, Riviere JE, Monteiro-Riviere NA. 2001a. Analysis 
of interleukin-8 release from normal human epidermal 
keratino  cytes exposed to aliphatic hydrocarbons: delivery 
of hydrocarbons to cell cultures via complexation with 
alpha-cyclodextrin. Toxicol In Vitro 15:663–669.
Allen DG, Riviere JE, Monteiro-Riviere NA. 2001b. Cytokine 
induction as a measure of cutaneous toxicity in primary 
and immortalized porcine keratinocytes exposed to jet Silver nanoparticle toxicity in vitro and in vivo
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 3 | March 2010  413
fuels, and their relationship to normal human epidermal 
keratinocytes. Toxicol Lett 119:209–217.
Arora S, Jain J, Rajwade JM, Paknikar KM. 2008. Cellular 
responses induced by silver nanoparticles: in vitro studies. 
Toxicol Lett 179:93–100.
Barker JN, Jones ML, Swenson CL, Sarma V, Mitra RS, Ward PA, 
et al. 1991. Monocyte chemotaxis and activating factor 
production by keratinocytes in response to IFN-gamma. 
J Immunol 146:1192–1197.
Benn TM, Westerhoff P. 2008. Nanaoparticle silver released into 
water from commercially available sock fabrics. Environ 
Sci Technol 42:4133–4139.
Braydich-Stolle L, Hussain S, Schlager J, Hofmann MC. 2005. 
In vitro cytotoxicity of nanoparticles in mammalian germ 
line stem cells. Toxicol Sci 88:412–419.
Bronaugh RL, Stewart RF, Congdon ER. 1982. Methods for 
in vitro percutaneous absorption studies II: animal models 
for human skin. Toxicol Appl Pharmacol 62:481–488.
Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, et al. 2007. 
A comparative study of the cytotoxicity of silver-based 
dressings in monolayer cell, tissue explant, and animal 
models. Wound Repair Regen 15:94–104.
Chou CC, Riviere JE, Monteiro-Rivere NA. 2002. Differential 
relationship between the carbon chain length of jet fuel ali-
phatic hydrocarbons and their ability to induce cytotoxicity 
vs. interleukin-8 release in human epidermal keratinocyties. 
Toxicol Sci 69:226–233.
Chou CC, Riviere JE, Monteiro-Riviere NA. 2003. The cyto  toxicity of 
jet fuel aromatic hydrocarbons and dose-related interleukin-8 
release from human epidermal keratinocytes. Arch Toxicol 
77:384–391.
Corsini E, Galli CL. 2000. Epidermal cytokines in experimental 
contact dermatitis. Toxicology 142:203–211.
Crede CSF. 1881. Die Verhutung der Augenentzundung der 
Neugeborenen. Arch Gynakol 17:50–53.
Cross SE, Brian I, Roberts MS. 2007. Human skin penetration of 
sunscreen nanoparticles: in vitro assessment of a novel 
micronized zinc oxide formulation. Skin Pharmacol Physiol 
20:148–154.
Danscher G. 1980. Light and electron microscopic localization of 
silver in biological tissue. Histochem Cell Biol 71:177–186.
Draize JH, Woodard G, Calvery HO. 1944. Methods for the 
study of irritation and toxicity of substances applied to 
the skin and mucous membranes. J Pharmacol Exp Ther 
82:377–390.
Fung MC, Bowen DL. 1996. Silver products for medical indica-
tions: risk-benefit assessment. Clin Toxicol 34:119–126.
Gamer AO, Leibold E, van Ravenzwaay B. 2006. The in vitro 
absorption of microfine zinc oxide and titanium dioxide 
through porcine skin. Toxicol In Vitro 20:301–307.
Gong P, Li H, He X, Wang K, Hu J, Tan W, et al. 2007. Preparation 
and antibacterial activity of Fe3O4–Ag nanoparticles. 
Nanotechnology 18:285604–285610. 
Grone A. 2002. Keratinocytes and cytokines. Vet Immunol 
Immunopathol 88:1–12.
Hussain S, Hess K, Gearhart J, Geiss K, Schlager J. 2005. In vitro 
toxicity of nanoparticles in BRL3A rat liver cells. Toxicol 
In Vitro 19:975–983.
Ku RH, Billings RE. 1984. Relationships between formaldehyde 
metabolism and toxicity and glutathione concentrations in 
isolated rat hepatocytes. Chem Biol Interact 51:25–36.
Larese FF, D’Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, 
et al. 2009. Human skin penetration of silver nanoparticles 
through intact and damaged skin. Toxicology 255:33–37.
Lee SM, Lee SH. 1994. Generalized argyria after habitual use of 
silver nitrate. J Dermatol 21:50–53.
Marshall JP, Schneider RP. 1977. Systemic argyria secondary 
to topical silver nitrate. Arch Dermatol 113:1077–1079.
Monteiro-Riviere N, Inman A, Riviere J. 2001. The effects of short-
term high-dose and low-dose dermal exposure to Jet A, 
JP-8, and JP-8+100 jet fuels. J Appl Toxicol 21:485–494. 
Monteiro-Riviere NA, Baynes RE, Riviere JE. 2003. Pyridostigmine 
bromide modulates topical irritant-induced cytokine release 
from human epidermal keratinocytes and isolated perfused 
porcine skin. Toxicology 183:15–28.
Monteiro-Riviere NA, Inman AO. 2006. Challenges for assess-
ing carbon nanomaterial toxicity to the skin. Carbon 
44:1070–1078.
Monteiro-Riviere NA, Inman AO, Riviere JE. 2004. Skin toxicity 
of jet fuels: ultrastructural studies and the effects of sub-
stance P. Toxicol Appl Pharmacol 195:339–347. 
Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations 
and relative utility of screening assays to assess engi-
neered nanoparticle toxicity in a human cell line. Toxicol 
Appl Pharmacol 234:222–235.
Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, 
Riviere JE. 2005. Multi-walled carbon nanotube inter-
actions with human epidermal keratinocytes. Toxicol Lett 
155:377–384.
Monteiro-Riviere NA, Riviere JE. 1996. The pig as a model for cuta-
neous pharmacology and toxicology research. In: Advances 
in Swine in Biomedical Research, Vol 2 (Tumbleson ME, 
Schook LB, eds). New York:Plenum, 425–458. 
Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW Jr. 
1965. Treatment of large human burns with 0.5% silver nitrate 
solution. Arch Surg 90:812–867. 
Muhammad  F,  Monteiro-Riviere  NA,  Riviere  JE.  2005. 
Comparative in vivo toxicity of topical JP-8 jet fuel and its 
individual hydrocarbon components: identification of tri-
decane and tetra  decane as key constituents responsible 
for dermal irritation. Toxicol Pathol 33:258–266.
National Center for Complementary and Alternative Medicine. 
2009. Colloidal Silver Products. Publication no. D209. 
Bethesda, MD:National Center for Complementary and 
Alternative Medicine. Available: http://nccam.nih.gov/
health/silver/ [accessed 7 February 2010]. 
National Institute for Occupational Safety and Health. 2003. 
Registry of Toxic Effects of Chemical Substances: Silver. 
RTECS #: VW3500000. CAS #: 7440-22-4. Available: http://
www.cdc.gov/niosh/rtecs/vw3567e0.html [accessed 
26 May 2009]. 
Nickoloff BJ, Varani J, Mitra RS. 1991. Modulation of keratino-
cyte biology by gamma interferon: relevance to cutaneous 
wound healing. Prog Clin Biol Res 365:141–154.
Project on Emerging Nanotechnologies. 2009. Analysis. 
Available: http://www.nanotechproject.org/inventories/
consumer/analysis_draft/ [accessed May 26, 2009].
Reifenrath WG, Chellquist EM, Shipwash EA, Jederberg WW. 
1984. Evaluation of animal models for predicting skin penetra-
tion in man. Fundam Appl Toxicol 4:S224–S230.
Rouse JG, Yang J, Barron AR, Monteiro-Riviere NA. 2007. 
Fullerene-based amino acid nanoparticle interactions with 
human epidermal keratinocytes. Toxicol In Vitro 8:1313–1320.
Rouse JG, Yang J, Ryman-Rasmussen J, Barron AR, Monteiro-
Riviere NA. 2006. Effects of mechanical flexion on the 
penetration of fullerene amino acid-derivatized peptide 
nanoparticles through skin. Nano Lett 7:155–160.
Rungby J, Danscher G. 1983. Localization of exogenous sil-
ver in brain and spinal cord of silver exposed rats. Acta 
Neuropathol 60:92–98.
Ryman-Rasmussen J, Riviere JE, Monteiro-Riviere NA. 2006. 
Penetration of intact skin by quantum dots with diverse 
physicochemical properties. Toxicol Sci 91:159–165.
Schrand AM, Braydich-Stolle LK, Schlager JJ, Dai L, Hussain SM. 
2008. Can silver nanoparticles be useful as potential biologi-
cal labels? Nanotechnology 19:235104.
Temple RM, Farooqi AA. 1985. An elderly, slate-grey woman. 
Practitioner 229:1053–1054.
U.S. Environmental Protection Agency. 2003. Silver (CASRN 
7440-22-4). Available: http://www.epa.gov/IRIS/subst/0099.
htm [accessed 27 May 2009]. 
Zhang LW, Monteiro-Riviere NA. 2008. Assessment of quantum 
dot penetration into intact, tape-stripped, abraded and 
flexed rat skin. Skin Pharmacol Physiol 21:166–180.
Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. 2008. 
Biological interactions of quantum dot nanoparticles in 
skin and in human epidermal keratinocytes. Toxicol Appl 
Pharmacol 2:200–211.
Zhang LW, Zeng L, Barron AR, Monteiro-Riviere NA. 2007. 
Biological interactions of functionalized single-wall carbon 
nanotubes in human epidermal keratinocytes. Int J Toxicol 
26:103–113